To further determine whether ERK signalling can regulate c-Myc and CDK6 and affect the phenotypes of LSCs and human AML cell lines, we used ERK1/2 inhibitors (U0126, 20 μM) in THP-1 cells. Here, CDK6 is linked to acute myeloid leukemia.